Xencor, Inc.
29.33USD
+4.1500 (+16.49%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on XNCR.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$0.34▲ | -$0.83 | 5 | 0 |
| Next quarter | -$0.79▼ | -$0.74 | 2 | 3 |
| Current year | -$3.07▲ | -$4.03 | 9 | 2 |
| Next year | -$3.53▲ | -$3.55 | 0 | 3 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$0.84 | -$0.29 | +0.55 (+65.6%) |
| 2026-03-31 | -$0.75 | -$1.71 | -0.96 (-129.0%) |
| 2025-12-31 | -$0.58 | -$0.09 | +0.49 (+84.6%) |
| 2025-09-30 | -$0.7 | -$0.08 | +0.62 (+88.6%) |
97 ratings from 26 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Wedbush | Reiterated | Outperform | $30 | Oct 21, 2026 |
| Truist Securities | Reiterated | Buy | $27 $29 | Sep 28, 2026 |
| B of A Securities | Maintained | Neutral | $20 $26 | Sep 21, 2026 |
| Barclays | Maintained | Overweight | $27 $35 | Sep 11, 2026 |
| JP Morgan | Maintained | Neutral | $14 $21 | Sep 3, 2026 |
| Raymond James | Maintained | Strong Buy | $40 $46 | Sep 1, 2026 |
| RBC Capital | Maintained | Outperform | $19 $20 | Aug 6, 2026 |
| Wedbush | Maintained | Outperform | $26 $30 | Aug 6, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $43 $44 | Aug 6, 2026 |
| Wedbush | Reiterated | Outperform | $26 | Jul 30, 2026 |
| Truist Securities | Maintained | Buy | $29 $27 | Jul 7, 2026 |
| JP Morgan | Maintained | Neutral | $13 $14 | May 11, 2026 |
| JP Morgan | Downgraded from Overweight | Neutral | $18 $13 | Mar 24, 2026 |
| Barclays | Maintained | Overweight | $26 $27 | Feb 26, 2026 |
| Barclays | Maintained | Overweight | $23 $26 | Dec 17, 2025 |
| Truist Securities | Initiated | Buy | $29 | Nov 24, 2025 |
| JP Morgan | Maintained | Overweight | $20 $18 | Nov 6, 2025 |
| RBC Capital | Maintained | Outperform | $18 $19 | Nov 6, 2025 |
| Cantor Fitzgerald | Maintained | Overweight | $40 $42 | Nov 6, 2025 |
| Barclays | Upgraded from Underweight | Overweight | $6 $23 | Oct 29, 2025 |
| RBC Capital | Maintained | Outperform | $15 $18 | Oct 27, 2025 |
| B of A Securities | Downgraded from Buy | Neutral | $23 $12 | Sep 3, 2025 |
| Wedbush | Reiterated | Outperform | $26 | Sep 2, 2025 |
| RBC Capital | Maintained | Outperform | $32 $15 | Aug 21, 2025 |
| Wells Fargo | Maintained | Overweight | $33 $27 | Aug 7, 2025 |
62 filings from 13 insiders · 8 buy / 5 sell over 6m
Officers and directors of XNCR, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| FEIGAL ELLEN G.Director | Sell | 6.8k | $13.06 | $89k | Jun 18, 2026 |
| DESHAIES RAYMOND JOSEPHDirector | Grant | 10.3k | — | — | Jun 16, 2026 |
| FEIGAL ELLEN G.Director | Grant | 10.3k | — | — | Jun 16, 2026 |
| KLENCKE BARBARA M.D.Director | Grant | 10.3k | — | — | Jun 16, 2026 |
| GUSTAFSON KURT ADirector | Grant | 10.3k | — | — | Jun 16, 2026 |
| GORMAN KEVIN CHARLESDirector | Grant | 10.3k | — | — | Jun 16, 2026 |
| RANIERI RICHARD JDirector | Grant | 10.3k | — | — | Jun 16, 2026 |
| SIMPSON TODD EDirector | Grant | 10.3k | — | — | Jun 16, 2026 |
| MONTGOMERY ALAN BRUCEDirector | Grant | 10.3k | — | — | Jun 16, 2026 |
| GUSTAFSON KURT ADirector | Sell | 5.5k | $12.31 | $67k | Jun 15, 2026 |
| GORMAN KEVIN CHARLESDirector | Sell | 7.5k | $12.31 | $93k | Jun 15, 2026 |
| RANIERI RICHARD JDirector | Sell | 5.5k | $12.31 | $67k | Jun 15, 2026 |
| MONTGOMERY ALAN BRUCEDirector | Sell | 5.1k | $12.31 | $62k | Jun 15, 2026 |
| CORNELISSEN BART JANChief Financial Officer | Sell | 3.5k | $12.29 | $43k | Apr 10, 2026 |
| ECKERT CELIA EGeneral Counsel | Sell | 5.0k | $11.02 | $56k | Mar 6, 2026 |
| DAHIYAT BASSIL ISHMAELChief Executive Officer | Sell | 21.5k | $11.02 | $240k | Mar 6, 2026 |
| DESJARLAIS JOHN ROfficer | Sell | 6.6k | $11.02 | $74k | Mar 6, 2026 |
| CORNELISSEN BART JANChief Financial Officer | Sell | 2.5k | $11.25 | $28k | Mar 5, 2026 |
| ECKERT CELIA EGeneral Counsel | Sell | 1.5k | $11.90 | $18k | Mar 3, 2026 |
| DAHIYAT BASSIL ISHMAELChief Executive Officer | Sell | 6.8k | $11.90 | $80k | Mar 3, 2026 |
No analyst notes on XNCR yet.
Analyst Ratings
12 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 9 | 2 | 0 | 0 | Buy1.93 |
| 1 mo ago | 3 | 9 | 2 | 0 | 0 | Buy1.93 |
| 2 mo ago | 3 | 9 | 2 | 0 | 0 | Buy1.93 |
| 3 mo ago | 3 | 9 | 2 | 0 | 0 | Buy1.93 |
Members whose judged calls on XNCR have played out most reliably.
No settled calls on XNCR yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice